Filing metadata

Accession number
0001209191-17-066692
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Dec 20, 2017
Reporting period
Dec 18, 2017
Description
Insider transaction

Explore SEC Filings Hub